FAP and neoplasm: Thus, FAP may be a particularly relevant immunotherapy target antigen, despite its heterogeneity of expression, because it would allow targeting of the invasive and/or stem‐like cells responsible for continued tumor growth and disease recurrence after standard treatments.12